These results are in line with those obtained by Romani et al. [43] but in contrast to those obtained by Baran et al.; they found no correlation between serum lipocalin-2 levels and disease severity, with serum lipocalin-2 levels not significantly influenced by topical treatment of psoriasis lesions [44]. This evidence concerns the gene LCN2 and psoriasis.